Coagulation management with factor concentrates in liver transplantation: a single‐center experience

Abstract

In LT, ROTEM-guided treatment with fibrinogen concentrate and/or PCC did not appear to increase the occurrence of thrombosis and ischemic events compared to patients who did not receive these concentrates.